Abstract
Tetracyclines are a class of antibiotics that function by inhibiting protein synthesis. Although they have a very broad spectrum of antibacterial activity, their current clinical use is primarily for the treatment of intracellular organisms like mycoplasma, chlamydia, and rickettsia. They are also used as alternative agents for the treatment of syphilis in the case of penicillin allergy.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsFurther Reading
Chemaly, R. F., Hanmod, S. S., Jiang, Y., Rathod, D. B., Mulanovich, V., Adachi, J. A., et al. (2009). Tigecycline use in cancer patients with serious infections: a report on 110 cases from a single institution. Medicine (Baltimore), 88(4), 211–220.
Edson, R. S., Bundrick, J. B., & Litin, S. C. (2011). Clinical pearls in infectious diseases. Mayo Clin Proc, 86(3), 245–248.
Roberts, J. A., & Lipman, J. (2009). Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med, 37(3), 840–851; quiz 859.
Smilack, J. D. (1999). The tetracyclines. Mayo Clin Proc, 74(7), 727–729.
Tigecycline (tygacil). (2005). Med Lett Drugs Ther, 47(1217), 73–74.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Finberg, R.W., Guharoy, R. (2012). Tetracyclines. In: Clinical Use of Anti-infective Agents. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-1068-3_13
Download citation
DOI: https://doi.org/10.1007/978-1-4614-1068-3_13
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-1067-6
Online ISBN: 978-1-4614-1068-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)